Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Women that have undiagnosed sexually transmitted infections may be at greater risk of experiencing negative premenstrual symptoms (PMS), according to new Oxford University research.

Image courtesy of Shutterstock

The study was conducted as part of a long term partnership with the female health, fertility and period-tracking app, CLUE. The findings, published in Evolution Medicine & Public Health, suggest that the presence of an undiagnosed STI might aggravate the negative premenstrual experience.

Despite being known to have an anti-social effect on women’s lives, altering their moods, energy levels, eating habits and even sex drive, periods are not recognised as a scientific factor in the study of female health. However, since some STI infections are asymptomatic, for instance 70% of people diagnosed with Chlamydia are unaware of it, and can lead to fertility issues, the study authors caution that these results are significant, and that reproductive health needs to be taken more seriously by both the scientific community and women in general.

Find out more (University of Oxford website)

Similar stories

Multi-partner 'OpenMind' consortium to develop technology for new generation of neurostimulation devices

General Research

Investigators at the University of Oxford, University of California San Francisco (UCSF), Brown University and the Mayo Clinic have joined forces to develop open-source technology platforms for a new generation of neurostimulation devices that not only provide stimulation to the brain but also sense, record, and stream brain activity.

Why we must expand newborn screening

General Research

Professor Laurent Servais of the Department of Paeditrics writes for the Oxford Science Blog on why it is important that we become much more efficient in the diagnosis of treatable conditions and in the treatment of these diseases.

New method for cost-effective genome-wide DNA methylation analysis

General Research

Ludwig Cancer Research team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.

Azithromycin not effective against COVID-19, trial confirms

Clinical Trials General Research

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.